Literature DB >> 6602061

T lymphocyte colonies stimulated by different mitogens require diverse culture conditions.

D G Tice, F R Davey.   

Abstract

Normal human peripheral blood mononuclear cells form colonies of T lymphocytes in a semi-solid agar matrix when stimulated by a variety of mitogens. In this report, we attempt to determine the optimal conditions for the formation of T lymphocyte colonies by cells stimulated with phytohemagglutinin (PHA), pokeweed mitogen (PWM), Concanavalin A (Con A), or Staphylococcal protein A (SPA). We conclude that optimal conditions differ for each mitogen used. Cultures stimulated by PWM or Con A showed a significant requirement for feeder layers composed of human peripheral blood mononuclear cells. Two-mercaptoethanol significantly enhanced the number of T-cell colonies when PWM, Con A, or SPA, but not PHA, were added as mitogens. Fetal calf serum (FCS) was required for optimal conditions when Con A or SPA but not PWM or PHA were used to stimulate mononuclear cells. Cells stimulated by PHA or PWM produced more T-cell colonies in a 2-step assay than a 1-step assay, whereas the reverse was true with Con A or SPA. Optimal cell concentrations, mitogen doses, and culture kinetics also differed for each mitogen used in the T-cell colony assay.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602061

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  3 in total

1.  The T-lymphocyte colony-forming cell (T-CFC): in vitro studies of progenitors and progeny.

Authors:  D G Tice; F R Davey
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

2.  T lymphocyte colonies are the progeny of single cells.

Authors:  D G Tice; F R Davey
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

Review 3.  Review: 2-mercaptoethanol alteration of in vitro immune functions of species other than murine.

Authors:  Robert E Click
Journal:  J Immunol Methods       Date:  2013-11-22       Impact factor: 2.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.